Case Details
- Title: CENTRE FOR LASER AND AESTHETIC MEDICINE PTE. LTD. v GOH PUI KIAT & 2 Ors
- Citation: [2017] SGHC 72
- Court: High Court of the Republic of Singapore
- Date: 6 April 2017
- Judges: Chua Lee Ming J
- Case Number: Suit No 672 of 2015
- Plaintiff/Applicant: Centre for Laser and Aesthetic Medicine Pte Ltd (“CLAM”)
- Defendants/Respondents: (1) Goh Pui Kiat (“Goh PK”) (2) Wong Hwee Leng (“Wong”) (3) GPK Clinic (Orchard) Pte Ltd (“GPKPL”)
- Legal Areas: Contract; Equity (fiduciary duties); Tort (breach of confidence; conspiracy)
- Statutes Referenced: Companies Act (Cap 50, 2006 Rev Ed)
- Key Procedural Dates: 4–6, 11, 17, 21 October 2016; 20 February 2017
- Judgment Length: 30 pages; 8,222 words
- Core Claims: Breach of fiduciary duties/good faith and fidelity; procurement/inducement of breach of employment contracts; breach of duty of confidentiality; breach of fiduciary duties by Wong; conspiracy to injure by unlawful means; damages and injunction
- Subsequent Appeals Noted in Extract: CLAM appealed (i) dismissal of most claims (confirming it was not pursuing employee-poaching claim), (ii) damages, and (iii) costs (40%); defendants appealed on costs
Summary
Centre for Laser and Aesthetic Medicine Pte Ltd v Goh Pui Kiat & 2 Ors ([2017] SGHC 72) arose from a long-running business and personal dispute between two couples who jointly operated a medical/aesthetic clinic business through a company, CLAM. The plaintiff alleged that the first defendant, Dr Goh Pui Kiat (“Goh PK”), and the third defendant, GPK Clinic (Orchard) Pte Ltd (“GPKPL”), used confidential patient and product information, diverted patients, failed to work assigned clinic days, and engaged in conduct that undermined CLAM’s operations. CLAM also alleged that the second defendant, Wong Hwee Leng (“Wong”), breached fiduciary duties in connection with these matters.
The High Court (Chua Lee Ming J) found in substance that the defendants breached CLAM’s duty of confidentiality and that Goh PK and GPKPL conspired to injure CLAM through Goh PK’s breach of confidentiality. However, the court dismissed CLAM’s other claims, including those relating to alleged failure to work, diversion of patients (as pleaded under the broader fiduciary duty framework), and procurement/inducement of employees to breach their employment contracts. The court directed the parties to compute damages using parameters it set out, and the parties later agreed on damages of $193,481.38. The court also ordered deletion/destruction of certain patient information and granted an injunction restraining use of such information without CLAM’s prior authorisation.
What Were the Facts of This Case?
CLAM was established in January 2006 by two doctors, Dr Kelvin Goh Yong Chiang (“Kelvin”) and Goh PK, who were also the de facto directors of CLAM at all material times. CLAM operated an aesthetic and general medical clinic known as Orchard MD Clinic & Surgery Singapore (“Orchard Clinic”) at Ngee Ann City Tower B #08-03. The business focus was aesthetic treatments relating to skincare. CLAM employed both Kelvin and Goh PK to work at the clinic, with their clinical and operational roles forming the core of the company’s value proposition.
Ownership and governance were closely tied to the personal relationships between the two couples. Jacqueline, Kelvin’s wife, and Wong, Goh PK’s wife, each held 50% of the shares in CLAM. The parties’ arrangement was that Kelvin and Goh PK split work days at Orchard Clinic. Kelvin’s assigned days were Tuesdays, Thursdays, and alternate Mondays and Saturdays; Goh PK’s assigned days were Wednesdays, Fridays, and alternate Mondays and Saturdays. Profits were split equally between the two couples, reflecting an expectation of mutual participation and loyalty in the joint venture.
In parallel, Goh PK and Wong were the two directors and equal shareholders of the third defendant, GPKPL, which owned and operated a competing clinic, GPK Clinic (Orchard), located in competition with CLAM and Orchard Clinic. The dispute therefore had both an internal corporate dimension (fiduciary and confidentiality obligations owed to CLAM) and an external competitive dimension (the operation of a rival clinic by the defendants).
Several agreements and disputes shaped the background. In 2007, Kelvin and Goh PK signed a Confidentiality Contract and Mutual Undertaking. Among other terms, it restricted them from practising aesthetic medicine on their own or jointly with third parties, from undertaking other employment or having interests in competing businesses, and from engaging in activities conflicting with the interests and operation of the aesthetic medicine practice. In 2010, the parties also signed a shareholder agreement addressing the sale of their stakes, and a separate 2010 agreement placed Kelvin in charge of business operations and development of the clinics. Later, Kelvin and Jacqueline set up SkintechMD Pte Ltd, prompting Goh PK to commence Suit No 1023 of 2013 against Kelvin for breach of the Confidentiality Contract. That suit was settled through mediation in February 2014, with a Settlement Agreement that, among other things, set a timetable for procuring a sale of CLAM and MPC and provided that the parties should continue to fulfil their responsibilities and operations pending sale.
After the settlement, Goh PK incorporated a new company to operate a clinic two units away from Orchard Clinic, initially using “8-11” in its name. The Ministry of Health wrote to Goh PK indicating he was not allowed to use the “8-11” name due to the ongoing dispute. Goh PK then changed the company and clinic names to GPKPL and GPK Clinic (Orchard). CLAM’s action was filed after a board authorisation process under s 216A of the Companies Act, reflecting the corporate law requirement for leave/authorisation to commence proceedings in the company’s name against directors or those in control.
What Were the Key Legal Issues?
The High Court had to determine whether Goh PK breached fiduciary duties and/or the duty of good faith and fidelity owed to CLAM, including whether he failed to perform his assigned work at Orchard Clinic since May 2014, diverted Orchard Clinic patients to GPK Clinic, and poached or solicited employees away from CLAM. These allegations were framed as breaches of loyalty and fidelity principles that apply to directors and de facto directors, as well as to those who effectively manage or control a company’s affairs.
CLAM also pleaded that Goh PK knowingly procured and/or induced CLAM’s employees to breach their employment contracts by instructing them to direct patients and prospective patients to GPKPL. This required the court to assess the elements of procurement/inducement in tort and/or equitable wrongdoing, as well as the evidential link between the alleged instructions and any actual breach of employment obligations.
In addition, the court had to decide whether Goh PK, Wong, and GPKPL breached their duty of confidentiality to CLAM by copying, using, reproducing, disclosing, or disseminating CLAM’s information relating to patients and its products. Finally, the court had to consider whether Goh PK, Wong, and GPKPL conspired with intent to injure CLAM by unlawful means, and whether CLAM was entitled to damages, deletion/destruction orders, and injunctive relief.
How Did the Court Analyse the Issues?
The court’s analysis proceeded by separating the pleaded causes of action and evaluating them against the evidence. While the extract does not reproduce the entire reasoning, the court’s ultimate findings show that the confidentiality-based claims were central and were proven to the court’s satisfaction. The court found that Goh PK and GPKPL breached CLAM’s duty of confidentiality. This finding implies that the court accepted that CLAM possessed information that was confidential in nature, that the defendants had access to it in circumstances giving rise to an obligation of confidence, and that the defendants used and/or disclosed it without authorisation. In commercial clinic settings, patient information and related product/treatment information are typically treated as confidential because they are not merely public facts; they are tied to the clinic’s business processes, patient relationships, and competitive advantage.
Having found a breach of confidentiality, the court then addressed the conspiracy claim. The court found that Goh PK and GPKPL were liable for conspiracy to injure CLAM through Goh PK’s breach of confidentiality. Conspiracy in this context requires proof of an agreement or combination to carry out an unlawful means intended to injure the claimant. The court’s reasoning, as reflected in the summary of liability, indicates that the breach of confidentiality constituted the relevant unlawful means, and that the evidence supported the inference that the defendants acted in concert with the requisite intent to harm CLAM’s interests.
By contrast, the court dismissed CLAM’s other claims. The dismissal of the fiduciary duty/good faith and fidelity claims (except as they were subsumed into the confidentiality findings) suggests that the court either found insufficient proof of the alleged failures and diversions to meet the legal thresholds, or found that the evidence did not establish the necessary causal connection between the alleged conduct and a breach of the specific duties pleaded. For example, allegations that a director failed to work assigned days may raise questions of whether such conduct breached a duty of loyalty or good faith, but the court would still require evidence that the failure was wrongful in the relevant legal sense and that it caused loss or was part of a scheme to undermine the company. Similarly, allegations of patient diversion and employee poaching often depend heavily on proof of conduct, intent, and causation.
The court also dismissed CLAM’s claim that Goh PK knowingly procured and/or induced employees to breach their employment contracts. Procurement/inducement claims typically require clear evidence that the defendant directed or encouraged employees to breach specific contractual obligations, and that the defendant knew of the contractual terms and the likelihood of breach. Where evidence is indirect, ambiguous, or fails to show knowledge and intention, courts may be reluctant to impose liability. The court’s dismissal indicates that CLAM did not meet the evidential burden for this cause of action, even though it succeeded on confidentiality and conspiracy through confidentiality.
On damages and remedies, the court adopted a structured approach. It directed the parties to compute damages based on parameters it set out, and the parties later agreed on a figure of $193,481.38. The court also ordered deletion of patient information that had not been seen by Goh PK at GPK Clinic as of the date of the decision, and destruction of hardcopy information. It further granted an injunction restraining the defendants from using any such information without CLAM’s prior authorisation. These remedies reflect the equitable and tort-based nature of confidentiality protection: the aim is not only compensation but also the prevention of continued misuse of confidential information.
What Was the Outcome?
The High Court found Goh PK and GPKPL liable for breach of confidentiality, and found Goh PK and GPKPL liable for conspiracy to injure CLAM through breach of confidentiality. All other claims were dismissed, including CLAM’s claims relating to failure to work, diversion of patients under the fiduciary duty framework, and procurement/inducement of employees to breach employment contracts. Wong’s liability was not sustained on the broader fiduciary and conspiracy claims as pleaded, given the court’s overall dismissal of the majority of CLAM’s claims.
In terms of relief, the court directed computation of damages using parameters it specified; the parties agreed damages of $193,481.38. The court ordered deletion and/or destruction of certain patient information and granted an injunction restraining use of such information without CLAM’s prior authorisation. On costs, after further submissions, the court ordered Goh PK and GPKPL to pay 40% of CLAM’s costs and disbursements, with party-and-party costs paid to be applied towards CLAM’s outstanding solicitor-and-client costs obligations, and any balance to reimburse Kelvin for costs he had paid on CLAM’s behalf. Appeals were subsequently filed by CLAM (on damages and costs, and on the dismissal of claims other than employee poaching, which CLAM confirmed it was not pursuing) and by the defendants on costs.
Why Does This Case Matter?
This case is a useful authority on how Singapore courts approach confidentiality and related conspiracy claims in the context of competitive clinic businesses and director/de facto director relationships. Even where a claimant fails to prove broader fiduciary breaches or procurement of contractual breaches, success on confidentiality can still yield meaningful damages and strong injunctive relief. Practitioners should note that confidentiality claims can be comparatively more “evidence-driven” and may succeed where broader loyalty-based allegations are not supported to the required standard.
The decision also illustrates the remedial toolkit available for confidentiality breaches: courts may order deletion and destruction of confidential patient information and grant injunctions to prevent further use. For healthcare and professional services businesses, this is particularly important because patient data is both commercially valuable and sensitive, and misuse can cause ongoing harm that damages alone may not adequately address.
From a corporate governance perspective, the case underscores that de facto directors and those effectively controlling company operations can be held to duties of confidence and may face conspiracy liability where unlawful means are established. For defendants, it highlights the risk of using or retaining patient information after leaving a company, especially where the information is not demonstrably authorised for use in a competing practice. For claimants, it demonstrates the importance of pleading and proving the specific elements of confidentiality and conspiracy, and of marshalling evidence that links access to confidential information with its subsequent use or dissemination.
Legislation Referenced
- Companies Act (Cap 50, 2006 Rev Ed), s 216A
Cases Cited
- [2017] SGHC 72 (as the reported decision itself)
Source Documents
This article analyses [2017] SGHC 72 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.